324
Views
6
CrossRef citations to date
0
Altmetric
Original Article: Research

A comparative proteomic study of Homoharringtonine-induced apoptosis in leukemia K562 cells

, , , , , , , , , & show all
Pages 2162-2169 | Received 10 Feb 2014, Accepted 12 Oct 2014, Published online: 14 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jingjing Zhang, Huayun Geng, Ling Liu & Hao Zhang. (2019) Synergistic cytotoxicity of homoharringtonine and etoposide in acute myeloid leukemia cells involves disrupted antioxidant defense. Cancer Management and Research 11, pages 1023-1032.
Read now

Articles from other publishers (5)

Lele Wang, Linlin Zhao, Guo Wei, Dieter Saur, Barbara Seidler, Junyan Wang, Chuanxin Wang & Tonggang Qi. (2018) Homoharringtonine could induce quick protein synthesis of PSMD11 through activating MEK1/ERK1/2 signaling pathway in pancreatic cancer cells. Journal of Cellular Biochemistry 119:8, pages 6644-6656.
Crossref
Xia Li, Xiufeng Yin, Huafeng Wang, Jiansong Huang, Mengxia Yu, Zhixin Ma, Chenying Li, Yile Zhou, Xiao Yan, ShuJuan Huang & Jie Jin. (2017) The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia. Oncotarget 8:8, pages 12764-12774.
Crossref
Hui Ling, Jie He, Hui Tan, Lan Yi, Fang Liu, Xiaoxia Ji, Youhua Wu, Haobin Hu, Xi Zeng, Xiaohong Ai, Hao Jiang & Qi Su. (2017) Identification of potential targets for differentiation in human leukemia cells induced by diallyl disulfide. International Journal of Oncology 50:2, pages 697-707.
Crossref
Joëlle Pérard-Viret, Laith Quteishat, Rana Alsalim, Jacques Royer & Françoise Dumas. 2017. 205 352 .
Hiroyoshi Ariga. (2015) Common Mechanisms of Onset of Cancer and Neurodegenerative Diseases. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 38:6, pages 795-808.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.